• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MAX 突变型小细胞肺癌表现出 MGA 依赖性非典型多梳抑制复合物活性受损。

MAX mutant small-cell lung cancers exhibit impaired activities of MGA-dependent noncanonical polycomb repressive complex.

机构信息

Cancer Genetics Group, Josep Carreras Leukaemia Research Institute, 08916 Barcelona, Spain.

Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, 08908 Barcelona, Spain.

出版信息

Proc Natl Acad Sci U S A. 2021 Sep 14;118(37). doi: 10.1073/pnas.2024824118.

DOI:10.1073/pnas.2024824118
PMID:34493659
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8449313/
Abstract

The MYC axis is disrupted in cancer, predominantly through activation of the MYC family oncogenes but also through inactivation of the MYC partner MAX or of the MAX partner MGA. MGA and MAX are also members of the polycomb repressive complex, ncPRC1.6. Here, we use genetically modified MAX-deficient small-cell lung cancer (SCLC) cells and carry out genome-wide and proteomics analyses to study the tumor suppressor function of MAX. We find that MAX mutant SCLCs have ASCL1 or NEUROD1 or combined ASCL1/NEUROD1 characteristics and lack MYC transcriptional activity. MAX restitution triggers prodifferentiation expression profiles that shift when MAX and oncogenic MYC are coexpressed. Although ncPRC1.6 can be formed, the lack of MAX restricts global MGA occupancy, selectively driving its recruitment toward E2F6-binding motifs. Conversely, MAX restitution enhances MGA occupancy to repress genes involved in different functions, including stem cell and DNA repair/replication. Collectively, these findings reveal that MAX mutant SCLCs have either ASCL1 or NEUROD1 or combined characteristics and are MYC independent and exhibit deficient ncPRC1.6-mediated gene repression.

摘要

MYC 轴在癌症中被打乱,主要是通过 MYC 家族癌基因的激活,但也通过 MYC 伴侣 MAX 或 MAX 伴侣 MGA 的失活。MGA 和 MAX 也是多梳抑制复合物 ncPRC1.6 的成员。在这里,我们使用遗传修饰的 MAX 缺陷型小细胞肺癌 (SCLC) 细胞进行全基因组和蛋白质组学分析,以研究 MAX 的肿瘤抑制功能。我们发现,MAX 突变 SCLC 具有 ASCL1 或 NEUROD1 或联合 ASCL1/NEUROD1 特征,并且缺乏 MYC 转录活性。MAX 恢复会触发分化表达谱的变化,而当 MAX 和致癌性 MYC 共表达时,这种变化会发生。尽管可以形成 ncPRC1.6,但 MAX 的缺乏限制了全局 MGA 占据,选择性地促使其募集到 E2F6 结合基序。相反,MAX 的恢复增强了 MGA 的占据,从而抑制了不同功能的基因,包括干细胞和 DNA 修复/复制。总的来说,这些发现表明,MAX 突变 SCLC 具有 ASCL1 或 NEUROD1 或联合特征,并且是 MYC 非依赖性的,并表现出 ncPRC1.6 介导的基因抑制缺陷。

相似文献

1
MAX mutant small-cell lung cancers exhibit impaired activities of MGA-dependent noncanonical polycomb repressive complex.MAX 突变型小细胞肺癌表现出 MGA 依赖性非典型多梳抑制复合物活性受损。
Proc Natl Acad Sci U S A. 2021 Sep 14;118(37). doi: 10.1073/pnas.2024824118.
2
Multi-Omics Analysis Identifies MGA as a Negative Regulator of the MYC Pathway in Lung Adenocarcinoma.多组学分析鉴定 MGA 为肺腺癌中 MYC 通路的负调控因子。
Mol Cancer Res. 2020 Apr;18(4):574-584. doi: 10.1158/1541-7786.MCR-19-0657. Epub 2019 Dec 20.
3
MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1.MAX 失活导致小细胞肺癌中 MYC-SWI/SNF 程序紊乱,并与 BRG1 产生合成致死性。
Cancer Discov. 2014 Mar;4(3):292-303. doi: 10.1158/2159-8290.CD-13-0799. Epub 2013 Dec 20.
4
Loss of MGA repression mediated by an atypical polycomb complex promotes tumor progression and invasiveness.非典型多梳复合物介导的 MGA 抑制丧失促进肿瘤进展和侵袭性。
Elife. 2021 Jul 8;10:e64212. doi: 10.7554/eLife.64212.
5
Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.Myc 与 Max 和 Miz1 相互作用,抑制 C/EBPdelta 启动子活性和基因表达。
Mol Cancer. 2010 Apr 28;9:92. doi: 10.1186/1476-4598-9-92.
6
Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation.在TP53和RB1失活的小细胞肺癌细胞中,MYC抑制对生长的抑制作用
Oncotarget. 2016 May 24;7(21):31014-28. doi: 10.18632/oncotarget.8826.
7
ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs.ASCL1和NEUROD1揭示了肺神经内分泌肿瘤的异质性并调控不同的基因程序。
Cell Rep. 2016 Aug 2;16(5):1259-1272. doi: 10.1016/j.celrep.2016.06.081. Epub 2016 Jul 21.
8
Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology.Ascl1 诱导的 Wnt11 调节小细胞肺癌的神经内分泌分化、细胞增殖和 E-钙黏蛋白表达,Wnt11 调节小细胞肺癌生物学。
Lab Invest. 2019 Nov;99(11):1622-1635. doi: 10.1038/s41374-019-0277-y. Epub 2019 Jun 23.
9
ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer.ASXL3 桥接 BRD4 与 BAP1 复合物并调控小细胞肺癌中的增强子活性。
Genome Med. 2020 Jul 15;12(1):63. doi: 10.1186/s13073-020-00760-3.
10
MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer.MAX 作为一种肿瘤抑制因子,可重排小细胞肺癌的代谢。
Cancer Cell. 2020 Jul 13;38(1):97-114.e7. doi: 10.1016/j.ccell.2020.04.016. Epub 2020 May 28.

引用本文的文献

1
Lethal co-expression intolerance underlies the mutually exclusive expression of ASCL1 and NEUROD1 in SCLC cells.致死性共表达不耐受是小细胞肺癌(SCLC)细胞中ASCL1和NEUROD1相互排斥表达的基础。
NPJ Precis Oncol. 2025 Mar 13;9(1):74. doi: 10.1038/s41698-025-00860-6.
2
NEUROD1: transcriptional and epigenetic regulator of human and mouse neuronal and endocrine cell lineage programs.NEUROD1:人类和小鼠神经元及内分泌细胞谱系程序的转录和表观遗传调节因子。
Front Cell Dev Biol. 2024 Jul 22;12:1435546. doi: 10.3389/fcell.2024.1435546. eCollection 2024.
3
MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer.MYC 激活会损害细胞内固有 IFNγ 信号转导,并赋予肺癌对抗 PD-1/PD-L1 治疗的抗性。
Cell Rep Med. 2023 Apr 18;4(4):101006. doi: 10.1016/j.xcrm.2023.101006. Epub 2023 Apr 11.
4
Polycomb group ring finger protein 6 suppresses Myc-induced lymphomagenesis.多梳蛋白家族环状指蛋白6抑制Myc诱导的淋巴瘤发生。
Life Sci Alliance. 2022 Apr 14;5(8). doi: 10.26508/lsa.202101344. Print 2022 Aug.
5
Killing SCLC: insights into how to target a shapeshifting tumor.杀死小细胞肺癌:探索针对形态多变肿瘤的新策略。
Genes Dev. 2022 Mar 1;36(5-6):241-258. doi: 10.1101/gad.349359.122.

本文引用的文献

1
MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer.MAX 作为一种肿瘤抑制因子,可重排小细胞肺癌的代谢。
Cancer Cell. 2020 Jul 13;38(1):97-114.e7. doi: 10.1016/j.ccell.2020.04.016. Epub 2020 May 28.
2
Multi-Omics Analysis Identifies MGA as a Negative Regulator of the MYC Pathway in Lung Adenocarcinoma.多组学分析鉴定 MGA 为肺腺癌中 MYC 通路的负调控因子。
Mol Cancer Res. 2020 Apr;18(4):574-584. doi: 10.1158/1541-7786.MCR-19-0657. Epub 2019 Dec 20.
3
deletion destabilizes MYC protein and abrogates Eµ- lymphomagenesis.缺失会使 MYC 蛋白不稳定,并阻断 Eµ-淋巴瘤的发生。
Genes Dev. 2019 Sep 1;33(17-18):1252-1264. doi: 10.1101/gad.325878.119. Epub 2019 Aug 8.
4
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.小细胞肺癌的分子亚型:人类和小鼠模型数据的综合。
Nat Rev Cancer. 2019 May;19(5):289-297. doi: 10.1038/s41568-019-0133-9.
5
The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis.MYC 转录因子网络:平衡代谢、增殖和致癌作用。
Front Med. 2018 Aug;12(4):412-425. doi: 10.1007/s11684-018-0650-z. Epub 2018 Jul 27.
6
MGA, L3MBTL2 and E2F6 determine genomic binding of the non-canonical Polycomb repressive complex PRC1.6.MGA、L3MBTL2 和 E2F6 决定非典型多梳抑制复合物 PRC1.6 的基因组结合。
PLoS Genet. 2018 Jan 30;14(1):e1007193. doi: 10.1371/journal.pgen.1007193. eCollection 2018 Jan.
7
PCGF6-PRC1 suppresses premature differentiation of mouse embryonic stem cells by regulating germ cell-related genes.PCGF6 - PRC1通过调控生殖细胞相关基因来抑制小鼠胚胎干细胞的过早分化。
Elife. 2017 Mar 17;6:e21064. doi: 10.7554/eLife.21064.
8
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.MYC驱动小细胞肺癌向一种对极光激酶抑制敏感的变异神经内分泌亚型发展。
Cancer Cell. 2017 Feb 13;31(2):270-285. doi: 10.1016/j.ccell.2016.12.005. Epub 2017 Jan 12.
9
A High-Density Map for Navigating the Human Polycomb Complexome.一张用于探索人类多梳蛋白复合体组的高密度图谱。
Cell Rep. 2016 Oct 4;17(2):583-595. doi: 10.1016/j.celrep.2016.08.096.
10
ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs.ASCL1和NEUROD1揭示了肺神经内分泌肿瘤的异质性并调控不同的基因程序。
Cell Rep. 2016 Aug 2;16(5):1259-1272. doi: 10.1016/j.celrep.2016.06.081. Epub 2016 Jul 21.